Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18271825 | 0.69 | LMNA (0.45) | LMNACA12CA1CA2CA3 | |
| SCHEMBL2333424 | 0.69 | LMNA (0.45) | LMNACA12CA1CA2CA3 | |
| SCHEMBL19124538 | 0.65 | LMNA (0.46) | LMNACA12CA1CA2CA3 | |
| SCHEMBL1008559 | 0.62 | LMNA (0.55) | LMNACA12CA1CA2CA3 | |
| SCHEMBL1008198 | 0.62 | LMNA (0.55) | LMNACA12CA1CA2CA3 | |
| SCHEMBL1007609 | 0.62 | LMNA (0.55) | LMNACA12CA1CA2CA3 | |
| SCHEMBL1005671 | 0.60 | LMNA (0.53) | LMNACA12CA1CA2CA3 | |
| SCHEMBL1007666 | 0.60 | LMNA (0.53) | LMNACA12CA1CA2CA3 | |
| SCHEMBL1007520 | 0.60 | LMNA (0.53) | LMNACA12CA1CA2CA3 | |
| SCHEMBL2331857 | 0.59 | LMNA (0.38) | LMNACA12CA1CA2CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020052545-A1 | METHOD FOR PREPARING BRIVARACETAM AND INTERMEDIATES THEREOF | 上海宣泰医药科技有限公司 | 2020-03-19 | — | — | WO | disclosed |